NCT00003413View on ClinicalTrials.gov

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

February 28, 2001

Study Completion Date

February 28, 2001

Conditions
Ovarian Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

carmustine

DRUG

cisplatin

DRUG

melphalan

DRUG

paclitaxel

PROCEDURE

peripheral blood stem cell transplantation

PROCEDURE

surgical procedure

Trial Locations (1)

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

All Listed Sponsors
collaborator

University of Maryland Greenebaum Cancer Center

OTHER

lead

University of Maryland, Baltimore

OTHER

NCT00003413 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer | Biotech Hunter | Biotech Hunter